DrugPatentWatch Database Preview
Details for Patent: 9,339,507
Which drugs does patent 9,339,507 protect, and when does it expire?
Patent 9,339,507 protects TYVASO and is included in one NDA.
This patent has twelve patent family members in seven countries.
Summary for Patent: 9,339,507
| Title: | Treprostinil administration by inhalation |
| Abstract: | Treprostinil can be administered using a metered dose inhaler. Such administration provides a greater degree of autonomy to patients. Also disclosed are kits that include a metered dose inhaler containing a pharmaceutical formulation containing treprostinil. |
| Inventor(s): | Olschewski; Horst (Graz, AT), Roscigno; Robert (Chapel Hill, NC), Rubin; Lewis J. (LaJolla, CA), Schmehl; Thomas (Giessen, DE), Seeger; Werner (Giessen, DE), Sterritt; Carl (Weybridge, GB), Voswinckel; Robert (Giessen, DE) |
| Assignee: | United Therapeutics Corporation (Silver Spring, MD) |
| Application Number: | 13/469,854 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,339,507 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Delivery; Device; |
Drugs Protected by US Patent 9,339,507
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Therap | TYVASO | treprostinil | SOLUTION;INHALATION | 022387-001 | Jul 30, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,339,507
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2654492 | Start Trial | |||
| China | 101495122 | Start Trial | |||
| European Patent Office | 2026816 | Start Trial | |||
| Spain | 2707548 | Start Trial | |||
| Japan | 2009537246 | Start Trial | |||
| Japan | 2014114269 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
